Resveratrol in Postmenopausal Women With High Body Mass Index

Phase 1 Completed 46 enrolled National Cancer Institute (NCI)

NaSingle-groupOpen-labelBasic science

Summary

This pilot phase I trial studies resveratrol in postmenopausal women with high body mass index. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of resveratrol may keep cancer from forming. Studying samples of blood and urine in the laboratory from postmenopausal women who are taking resveratrol may help doctors learn more about the effects of resveratrol on biomarkers.

Timeline

Start: 2011-06
Primary completion: 2012-07
Completion: 2012-07

Publications

Chow HH, Garland LL, Heckman-Stoddard BM, Hsu CH, Butler VD, Cordova CA, Chew WM, Cornelison TL. A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J Transl Med. 2014 Aug 14;12:223. doi: 10.1186/s12967-014-0223-0.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Resveratrol	Small molecule	1 g	Oral

Indications

No indication recorded.